An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Several experts stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or prison.
Platform Reaction and Material Elimination
According to TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Marketplace Operations
Research also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at residence.
After moments of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.
Item Details and Costs
Inside these communities, messages display black plastic parcels with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious health risks”.
